Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens

被引:73
作者
Yamasaki, H
机构
[1] Unit of Multistage Carcinogenesis, Intl. Agy. for Res. on C., 69372 Lyon Cedex 08, 150, cours Albert Thomas
来源
MUTATION RESEARCH-REVIEWS IN GENETIC TOXICOLOGY | 1996年 / 365卷 / 1-3期
关键词
D O I
10.1016/S0165-1110(96)90014-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Results from short-term tests for carcinogens and our advanced knowledge on cellular and molecular mechanisms of carcinogenesis strongly suggest that carcinogens do not induce genetic changes necessarily by directly interacting with DNA. Therefore, it is not surprising to see that many carcinogens are not detectable by available genetic toxicology tests. Thus, it has become necessary to study nongenotoxic mechanisms of carcinogenesis and to provide methods to predict those carcinogens which escape from conventional mutation tests. One possible nongenotoxic mechanism of carcinogenesis which is supported by abundant experimental evidence is inhibition of gap junctional intercellular communication. Many, but not all, tumor-promoting agents have been shown to inhibit the communication of cultured cells as well as in vivo. Molecular mechanisms of gap junctional intercellular communication control revealed that connexin (gap junction) genes form a family of tumor suppressor genes. Control mechanisms of expression as well as function of connexins are vulnerable to various carcinogenic insults, notably to nongenetoxic carcinogens. Thus, studies on the role of connexins in cell growth and carcinogenesis may prove to be useful for establishing a mechanism-based test to detect certain types of nongenotoxic carcinogens.
引用
收藏
页码:91 / 105
页数:15
相关论文
共 106 条
[11]  
BERTHOUD VM, 1993, EUR J CELL BIOL, V62, P384
[12]  
Beyer E C, 1993, Int Rev Cytol, V137C, P1
[13]  
BOND SL, 1994, CELL GROWTH DIFFER, V5, P179
[14]   MUTATIONS OF THE CONNEXIN43 GAP-JUNCTION GENE IN PATIENTS WITH HEART MALFORMATIONS AND DEFECTS OF LATERALITY [J].
BRITZCUNNINGHAM, SH ;
SHAH, MM ;
ZUPPAN, CW ;
FLETCHER, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1323-1329
[15]   NULL MUTATIONS OF CONNEXIN32 IN PATIENTS WITH X-LINKED CHARCOT-MARIE-TOOTH DISEASE [J].
BRUZZONE, R ;
WHITE, TW ;
SCHERER, SS ;
FISCHBECK, KH ;
PAUL, DL .
NEURON, 1994, 13 (05) :1253-1260
[16]   CELL-CULTURE ASSAYS FOR CHEMICALS WITH TUMOR-PROMOTING OR TUMOR-INHIBITING ACTIVITY-BASED ON THE MODULATION OF INTERCELLULAR COMMUNICATION [J].
BUDUNOVA, IV ;
WILLIAMS, GM .
CELL BIOLOGY AND TOXICOLOGY, 1994, 10 (02) :71-116
[17]   APIGENIN AND TANGERETIN ENHANCE GAP JUNCTIONAL INTERCELLULAR COMMUNICATION IN RAT-LIVER EPITHELIAL-CELLS [J].
CHAUMONTET, C ;
BEX, V ;
GAILLARDSANCHEZ, I ;
SEILLANHEBERDEN, C ;
SUSCHETET, M ;
MARTEL, P .
CARCINOGENESIS, 1994, 15 (10) :2325-2330
[18]   CERAMIDE REVERSES BREFELDIN-A (BFA) RESISTANCE IN BFA-RESISTANT CELL-LINES [J].
ODA, T ;
CHEN, CH ;
WU, HC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) :4088-4092
[19]   INFECTION OF RAT-LIVER EPITHELIAL-CELLS WITH V-HA-RAS - CORRELATION BETWEEN ONCOGENE EXPRESSION, GAP JUNCTIONAL COMMUNICATION, AND TUMORIGENICITY [J].
DEFEIJTER, AW ;
RAY, JS ;
WEGHORST, CM ;
KLAUNIG, JE ;
GOODMAN, JI ;
CHANG, CC ;
RUCH, RJ ;
TROSKO, JE .
MOLECULAR CARCINOGENESIS, 1990, 3 (02) :54-67
[20]   INVOLVEMENT OF GAP-JUNCTIONS IN TUMORIGENESIS - TRANSFECTION OF TUMOR-CELLS WITH CONNEXIN-32 CDNA RETARDS GROWTH-INVIVO [J].
EGHBALI, B ;
KESSLER, JA ;
REID, LM ;
ROY, C ;
SPRAY, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10701-10705